SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile ...
Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the release of the CLARITY mobile app. (Logo: http://mma.prnewswire.com ...
Dexcom has become the first company to launch a generative AI-powered continuous glucose monitor. The San Diego healthcare company announced the launch of its proprietary product after leveraging ...
Dexcom ($DXCM) unveiled new data-sharing capabilities for its cloud-based diabetes management platform, Clarity. Now, patients and physicians may easily share data ...
> Dexcom added the Ambulatory Glucose Profile report, developed by the International Diabetes Center, into its web-based Clarity platform in Europe. The AGP provides physicians and healthcare ...
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback